CIC   05421
CENTRO DE INVESTIGACIONES CARDIOVASCULARES "DR. HORACIO EUGENIO CINGOLANI"
Unidad Ejecutora - UE
artículos
Título:
The specific inhibition of the cardiac electrogenic sodium/bicarbonate cotransporter leads to cardiac hypertrophy
Autor/es:
PORTIANSKY, ENRIQUE; VALVERDE, CARLOS A.; ORLOWSKI, ALEJANDRO; BLANCO, PAULA G.; DIAZ ZEGARRA, LEANDRO; AIELLO, ERNESTO A.; DI MATTIA, ROMINA A.; JAQUENOD DE GIUSTI, CAROLINA; GONANO, LUIS A.
Revista:
Physiological Mini Reviews
Editorial:
the Argentinean Physiological Society and the Latin American Association of Physiological Sciences
Referencias:
Año: 2021
ISSN:
1669-5410
Resumen:
Introduction: The Na+/HCO3- cotransporter (NBC) is one of the main alkalinizing transporters on cardiomyocytes. There are twoisoforms of NBC: the electrogenic NBCe1 and the electroneutral NBCn1. Although both isoforms enters Na+ into the cell, NBCe1contributes with half of Na+ per HCO3-, so it has a major efficiency. We have previously found a reduction of NBCe1 activitytogether with an increased NBCn1 activity in cardiac hypertrophy (CH) models.Aims: We developed an interference RNA cloned in a cardiotropic adeno-associated vector (AAV9-shNBCe1) to study the effectof the specific inhibition of NBCe1 in CH. Methodology: We delivered the virus through a lateral tail vein injection in male 3months old Wistar rats and then performed a series of studies to assess CH, using an AAV9-shControl as control. Data is expressedas means±S.E.M. and is compared with Student's t-test or two-way ANOVA test as needed. Results: After 30 days of injection, weconfirm a significant reduction on NBCe1 ventricular expression and activity. In addition, we found an increase in left ventr icularmass index obtained by echocardiography on hearts injected with AAV9-shNBCe1 (AAV9-shControl: 1.01±0.1; n=11; AAV9-shNBCe1*: 1.46±0.11, n=11; *p